MEDIFAST INC

Company Profile

MEDIFAST INC had its IPO on 1993-12-31 under the ticker symbol MED.

The company operates in the Consumer Cyclical sector and Personal Services industry. MEDIFAST INC has a staff strength of 874 employees.

Stock update

Shares of MEDIFAST INC opened at $82.82 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $80.81 - $83.48, and closed at $81.94.

This is a -1.06% slip from the previous day's closing price.

A total volume of 161,955 shares were traded at the close of the day’s session.

In the last one week, shares of MEDIFAST INC have slipped by -2.45%.

MEDIFAST INC's Key Ratios

MEDIFAST INC has a market cap of $884.44 million, indicating a price to book ratio of 8.8601 and a price to sales ratio of 0.7609.

In the last 12-months MEDIFAST INC’s revenue was $1.37 billion with a gross profit of $1.14 billion and an EBITDA of $185.12 million. The EBITDA ratio measures MEDIFAST INC's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, MEDIFAST INC’s operating margin was 12.6% while its return on assets stood at 32.8% with a return of equity of 84.39%.

In Q2, MEDIFAST INC’s quarterly earnings growth was a negative -19% while revenue growth was a negative 34.7%.

MEDIFAST INC’s PE and PEG Ratio

Forward PE

0

Trailing PE

6.6848

PEG

1.95

Its diluted EPS in the last 12-months stands at $12.15 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 1.95. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into MEDIFAST INC’s profitability.

MEDIFAST INC stock is trading at a EV to sales ratio of 0.788 and a EV to EBITDA ratio of 6.1516. Its price to sales ratio in the trailing 12-months stood at 0.7609.

MEDIFAST INC stock pays annual dividends of $6.58 per share, indicating a yield of 8.13% and a payout ratio of 50.77%.

Balance sheet and cash flow metrics

Total Assets

$318.73 million

Total Liabilities

$114.90 million

Operating Cash Flow

$-1744000.00

Capital Expenditure

$1.74 million

Dividend Payout Ratio

50.77%

MEDIFAST INC ended 2024 with $318.73 million in total assets and $0 in total liabilities. Its intangible assets were valued at $318.73 million while shareholder equity stood at $185.56 million.

MEDIFAST INC ended 2024 with $0 in deferred long-term liabilities, $114.90 million in other current liabilities, 11000.00 in common stock, $163.89 million in retained earnings and $0 in goodwill. Its cash balance stood at $147.41 million and cash and short-term investments were $147.41 million. The company’s total short-term debt was $5,405,000 while long-term debt stood at $0.

MEDIFAST INC’s total current assets stands at $228.82 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $105.19 million and inventory worth $68.90 million.

In 2024, MEDIFAST INC's operating cash flow was $-1744000.00 while its capital expenditure stood at $1.74 million.

Comparatively, MEDIFAST INC paid $0.51 in dividends in 2024.

Other key metrics

Current Trading Price

$81.94

52-Week High

$126.7783

52-Week Low

$76.2183

Analyst Target Price

$80

MEDIFAST INC stock is currently trading at $81.94 per share. It touched a 52-week high of $126.7783 and a 52-week low of $126.7783. Analysts tracking the stock have a 12-month average target price of $80.

Its 50-day moving average was $91.23 and 200-day moving average was $97.79 The short ratio stood at 8.38 indicating a short percent outstanding of 0%.

Around 213.5% of the company’s stock are held by insiders while 9609% are held by institutions.